Clinical trial · Interventional
Pringle's Maneuver Versus Selective Hepatic Vascular Exclusion in Hepatectomy
Pringle's Maneuver Versus Selective Hepatic Vascular Exclusion in Hepatectomy About Recurrence and Survival :A Prospective Randomized Trial
NCT00820339CI-TRIAL-00021594SHVEcompletedPhase 2 / Phase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To confirm that SHVE is a safe and effective procedure and it can prevent bleeding of the hepatic vein. To evaluate the recurrence and metastasis in HCC patients undergoing hepatectomy by SHVE.To evaluate that SHVE can improve survival in HCC patients or not.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatocellular Carcinoma | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Pringle's Maneuver | Procedure | — | UNRESOLVED |
| Selective Hepatic Vascular Exclusion | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Selective Hepatic Vascular Exclusion
- description
- Patients with HCC received Selective Hepatic Vascular Exclusion in hepatectomy.
- interventionNames
- Procedure: Selective Hepatic Vascular Exclusion
- type
- EXPERIMENTAL
- label
- Pringle's Maneuver
- description
- Patients with HCC received Pringle's Maneuver in hepatectomy.
- interventionNames
- Procedure: Pringle's Maneuver
Primary outcomes (1)
- measure
- Overall survival
- timeFrame
- 1,2,or 3 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Corresponding to diagnostic standards of HCC. * Patients of liver tumors underwent resection with occlusion of more than one main hepatic veins. * liver function in the Child-Pugh classification A or B. * Age between 18\~70 years. * Haven't taken any current treatment. * Understanding and being willing to sigh the informed consent form. Exclusion Criteria: * cannot be follow-up * severe liver, renal, or brain dysfunction * with tumor thrombi in the main trunk of portal vein * with tumor thrombi in the hepatic vein * with extrahepatic metastasis
References
Publications (0)
Data not yet available
No reference posted for this study.